Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock

British Journal of Pharmacology

Volumn 110, Issue 1, 1993, Pages 177-182

  Thiemermann, Christoph ^a   Wu, Chin‐Chen ^a   Szabó, Csaba ^a   Perretti, Mauro ^a   Vane, John R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

aorta; contraction; endotoxin shock; Nitric oxide; noradrenaline; vasodilatation

Indexed keywords

ENDOTOXIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORADRENALIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION; VASOCONSTRICTION;

AMINO ACID OXIDOREDUCTASES; ANESTHESIA; ANIMAL; ANTIBODIES, MONOCLONAL; AORTA, THORACIC; ENZYME INDUCTION; HEMODYNAMICS; IN VITRO; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; NOREPINEPHRINE; RATS; RATS, WISTAR; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0027237013     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1993.tb13789.x     Document Type: Article

References (55)

1. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo
2. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock
3. A rapid and sensitive method for the quantification of protein dye binding
4. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock
5. Interferon gamma and tumor necrosis factor induce the L‐arginine‐dependent cytotoxic effector mechanism in murine macrophages
6. Nitric oxide mediates tumour necrosis factor‐α cytotoxicity in endothelial cells
7. Molecular regulation of tumor necrosis factor‐α and lymphotoxin production in T cells
8. α, circulating blood cells, and the survival of rats
9. RP 55778, a PAF receptor antagonist, prevents and reverses hemoconcentration and TNF release
10. The cardiodepressant and vasodepressant effects of tumour necrosis factor in rat isolated atrial and aortic tissues
11. Interferon‐γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells
12. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF)
13. Loss of vascular responsiveness induced by endotoxin involves the L‐arginine pathway
14. Endothelial cell production of nitrogen oxides in response to interferon in combination with tumor necrosis factor, interleukin‐1 or endotoxin
15. Overproduction of nitric oxide in cytokine‐mediated and septic shock
16. G‐methyl‐L‐arginine inhibits tumor necrosis factor‐induced hypotension: implications for the involvement of nitric oxide
17. Time course of various inflammatory mediators during recurrent endotoxaemia
18. Anti‐inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat
19. Synergistic stimulation of nitric oxide hemoglobin production in rats by recombinant interleukin 1 and tumor necrosis factor
20. Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis
21. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774
22. Endogenous glucocorticoids regulate an inducible cyclo‐oxygenase enzyme
23. Participation of tumour necrosis factor in the mediation of gram negative bacterial lipopolysaccharide‐induced injury in rabbits
24. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis
25. Detection of circulating tumor necrosis factor after endotoxin administration
26. Characterization of nitric oxide synthase in non‐adrenergic‐non‐cholinergic nerves containing rat anococcygeus
27. Nitric oxide: physiology, pathophysiology, and pharmacology
28. G‐nitroarginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro
29. Involvement of nitric oxide in the PAF‐induced relaxation of rat thoracic aorta
30. Nitric oxide as a secretory product of mammalian cells
31. Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. Coli lipopolysaccharide in rats
32. Modulation of IL‐1‐induced neutrophil migration by dexamethasone and lipocortin‐1
33. Platelet‐activating factor (PAF) and tumour necrosis factor‐α (TNFα) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist
34. Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells
35. Dexamethasone prevents the induction of a nitric oxide synthase and the associated effects on the vascular tone: an insight into endotoxic shock
36. 2 and cyclic nucleotides
37. Pentoxyfilline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor
38. 4
39. Prophylactic and therapeutic effects of a monoclonal antibody to tumour necrosis factor‐α in experimental gram‐negative septic shock
40. Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration
41. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells
42. In vivo and in vitro effects of endotoxin on vascular responsiveness to noradrenaline and signal transduction in the rat
43. Nitric‐oxide mediated hyporeactivity to noradrenaline precedes nitric oxide synthase induction in endotoxin shock
44. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide
45. An antagonist of platelet‐activating factor (WEB 2086) inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide
46. Tumor necrosis factor‐α induces vascular hyporesponsiveness in Sprague‐Dawley rats
47. Vascular hyporeactivity to vasoconstrictor agents and haemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide
48. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo
49. Anti‐cachetin/TNF monoclonal antibodies prevent septic shock during lethal bateraemia
50. Shock and tissue injury induced by recombinant human cachectin
51. Nitric oxide and tumour necrosis factor in terminal arterioles of rat skeletal muscle
52. Production and clearance of tumor necrosis factor exposed to endotoxin and dexamethasone
53. Monoclonal antibody to tumor necrosis factor α attenuates cardiopulmonary dysfunction in porcine gram‐negative sepsis
54. Protective and pathological roles of nitric oxide in endotoxin shock
55. Differential regulation of lipopolysaccharide‐induced interleukin‐1 and tumour necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis